Bank of America’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $152 | Buy |
|
|||||
|
2025
Q1 | $140 | Buy |
|
|||||
|
2024
Q4 | $241 | Sell |
|
|||||
|
2024
Q3 | $370 | Buy |
|
|||||
|
2024
Q2 | $504 | Buy |
|
|||||
|
2024
Q1 | $564 | Sell |
|
|||||
|
2023
Q4 | $287 | Buy |
|
|||||
|
2023
Q3 | $200 | Sell |
|
|||||
|
2023
Q2 | $10.7K | Buy |
|
|||||
|
2023
Q1 | $16K | Sell |
|
|||||
|
2022
Q4 | $9.56K | Buy |
|
|||||
|
2022
Q3 | $23K | Sell |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $24K | Buy |
|
|||||
|
2021
Q4 | $12K | Sell |
|
|||||
|
2021
Q3 | $38K | Sell |
|
|||||
|
2021
Q2 | $138K | Sell |
|
|||||
|
2021
Q1 | $184K | Buy |
|
|||||
|
2020
Q4 | $213K | Buy |
|
|||||
|
2020
Q3 | $654K | Sell |
|
|||||
|
2020
Q2 | $718K | Buy |
|
|||||
|
2020
Q1 | $219K | Buy |
|
|||||
|
2019
Q4 | $98K | Buy |
|
|||||
|
2019
Q3 | $82K | Hold |
|
|||||
|
2019
Q2 | $83K | Hold |
|
|||||
|
2019
Q1 | $91K | Buy |
|
|||||
|
2018
Q4 | $71K | Hold |
|
|||||
|
2018
Q3 | $76K | Hold |
|
|||||
|
2018
Q2 | $78K | Buy |
|
|||||
|
2018
Q1 | $47K | Hold |
|
|||||
|
2017
Q4 | $59K | Sell |
|
|||||
|
2017
Q3 | $62K | Buy |
|
|||||
|
2017
Q2 | $62K | Hold |
|
|||||
|
2017
Q1 | $64K | Hold |
|
|||||
|
2016
Q4 | $38K | Buy |
|
|||||
|
2016
Q3 | $24K | Buy |
|
|||||
|
2016
Q2 | $24K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $178K | Buy |
|